SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

Study (n=1909) found overall, 16.6% of patients had at least one sequela from COVID-19 at the first oncological reassessment, with highest prevalence in pre-vaccination phase (191 of 1000 [19.1%]), confirming protective role of previous SARS-CoV-2 immunisation.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news